MedPath

Cardiovascular Consequences of Intermittent Hypoxia in Healthy Subjects

Not Applicable
Conditions
Sleep Apnea Syndrome
Registration Number
NCT00746928
Lead Sponsor
University Hospital, Grenoble
Brief Summary

The study is a prospective field evaluation to assess the effects of the chronic Intermittent Hypoxia exposure in 12 healthy humans.

Precisely, the study was designed to :

Set up a new model of Chronic Intermittent Hypoxia (CIH) applied to healthy human. This CIH is mimicking the CIH undergone by patients suffering from Sleep Apnea Syndrome.

Evaluate the cardiovascular effect of CIH. Neuronal and humoral sympathetic control, blood pressure control, vascular resistance.

Evaluate the Sleep quality, the ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex).

Investigates the biological aspects of CIH exposure.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Healthy subjects
Exclusion Criteria
  • Any history or significant medical condition

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Blood PressureTwo Weeks
Secondary Outcome Measures
NameTimeMethod
The ventilation under exposure and the long terms effect on ventilation control of CIH (central and peripheral chemoreflex)two weeks
Sleep qualityTwo Weeks
Neuronal and humoral sympathetic control and vascular resistance.Two weeks

Trial Locations

Locations (1)

Pulmonary Function and sleep Lab, CHU Grenoble

🇫🇷

Grenoble, France

© Copyright 2025. All Rights Reserved by MedPath